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Abstract
Background: Methadone is the therapeutic agent of choice for the treatment of opiate addiction
in pregnancy. The co-consumption (heroin, cocaine) which may influence the effects of methadone
is frequent. Therefore, the impact of cocaine and heroin on the placental transfer of methadone
and the placental tissue was investigated under in vitro conditions.
Methods: Placentae (n = 24) were ex-vivo perfused with medium (m) (control, n = 6), m plus
methadone (n = 6), m plus methadone and cocaine (n = 6) or m plus methadone and heroin (n =
6). Placental functionality parameters like antipyrine permeability, glucose consumption, lactate
production, hormone production (hCG and leptin), microparticles release and the expression of
P-glycoprotein were analysed.
Results: Methadone accumulated in placental tissue. Methadone alone decreased the transfer of
antipyrine from 0.60 +/- 0.07 to 0.50 +/- 0.06 (fetal/maternal ratio, mean +/- SD, P < 0.01), whereas
the combination with cocaine or heroin increased it (0.56 +/- 0.08 to 0.68 +/- 0.13, P = 0.03 and
0.58 +/- 0.21 to 0.71 +/- 0.24; P = 0.18). Microparticles (MPs) released from syncytiotrophoblast
into maternal circuit increased by 30% after cocaine or heroin (P < 0.05) and the expression of P-
glycoprotein in the tissue increased by ≥ 49% after any drug (P < 0.05). All other measured
parameters did not show any significant effect when methadone was combined with cocaine or
heroine.
Conclusion:  The combination of cocaine or heroin with methadone increase antipyrine
permeability. Changes of MPs resemble findings seen in oxidative stress of syncytiotrophoblast.
Background
In developed countries an increase in substance abuse in
pregnancy can be observed. Opiates cross the placenta
easily and lead to intrauterine growth restriction (IUGR),
preterm birth and spontaneous abortion [1-4]. Absti-
nence cannot be achieved in most of the patients and
methadone is the recommended standard of care for preg-
nant opioid-dependent women [5]. The positive effects of
methadone are an increase in birth weight and the prolon-
gation of gestation [4,6]. In addition, women in a mainte-
nance therapy program receive more prenatal care which
improves the situation for both, mother and fetus. How-
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ever, the main disadvantage of this therapy is the neonatal
abstinence syndrome (NAS) which occurs in 60–80% of
the newborns from mothers who consumed methadone
and is more intensive than in babies who were prenatally
exposed to heroin [3,7]. NAS due to opiate withdrawal
may result in disruption of the mother-infant relation-
ship, sleep-wake abnormalities, feeding difficulties,
weight loss and seizures. It's unclear whether the maternal
methadone dose correlates with the intensity and dura-
tion of NAS [5,8]. Nevertheless, transfer rates of metha-
done are higher from the fetal to the maternal circuit than
vice versa [9]. This phenomenon is based on the fact that
methadone is a substrate of the ATP-dependent efflux
transporter protein, the P-glycoprotein (P-gp) which is
expressed in the brush-border membranes of the maternal
derived syncytiotrophoblast and works against the con-
centration gradient [7,9,10]. Because co-consumption of
methadone with other drugs such as cocaine and heroin is
frequent, additional drugs may influence the placental
transfer of methadone and other substances by different
mechanisms. In case of inhibition of the P-gp function by
other drugs, the placental barrier may disrupt, and P-gp
substrates may increasingly transfer to fetal circulation
[11,12]. However, there exist no information whether her-
oin or cocaine are substrates of P-gp. Another mechanism
is that of apoptosis or necrosis of the syncytiotrophoblast
caused by some drugs. The syncytiotrophoblast is rela-
tively thick in early pregnancy. At first trimester there is
less syncytiotrophoblast and mostly of the trophoblast is
cytotrophoblast. With increasing gestational age there is a
differentiation of cytotrophoblast to syncytiotrophoblast.
The release of microparticles shed from the syncytiotro-
phoblast into the maternal blood is generated during
apoptosis or necrosis. MPs are larger than 100 nm in
diameter and originate from blebbing membranes of
either activated cells or cells undergoing apoptosis and
mainly consist of nuclear proteins as well as nucleic acids
[13]. The efficiency of transfer may be reduced by thicken-
ing of the basement membranes of capillary endothelium,
obliteration of maternal vessels and the increase of the
fibrinoid deposits [14-16]. Both mechanisms may affect
the incidence and intensity of NAS. Cocaine as opiates
leads to spontaneous abortion, low birth weight, fetal
growth restriction and in addition to impaired neurode-
velopment [17,18]. Because of its vasoactivity, cocaine
affects the fetal vasculature and impairs placental permea-
bility [19]. Heroin may be involved in leptin metabolism.
Leptin is produced in the placenta [20,21] and regulates
fetal growth and angiogenesis. In pregnancies with heroin
abuse [22] as well as with IUGR [23], umbilical cord
blood levels of leptin are reduced. It can therefore be
assumed that heroin abuse in pregnancy may reduce pla-
cental leptin synthesis and contributes to IUGR by reduc-
ing fetal growth. Similar effects of methadone or cocaine
on leptin are still unknown.
The aim of this study was therefore to investigate the pla-
cental transfer of methadone without and with addition
of cocaine or heroin in the ex-vivo placenta perfusion
model. Thereby placental functions as well as the
response of the placental tissue on methadone were key
issues.
Methods
Placenta collection
Intact placentae were consecutively obtained from
uncomplicated term pregnancies after caesarean section at
our Department. All women provided written informed
consent for the study which was approved by the local
institutional review board (KEK-StV-Nr. 07/07).
Placenta perfusion
Placentae were used for perfusion within 20–30 minutes
after delivery. For the dual ex-vivo perfusion (earlier so
called as "in-vitro" perfusion) of an isolated cotyledon the
method originally described 1972 by Schneider, Panigel
and Dancis [24] with a closed perfusion system for both
maternal and fetal circuits was used [25]. The perfusion
medium was composed of NCTC-135 tissue culture
medium (ICN Biomedicals, Inc., Irvine, California, USA)
diluted with Earle's buffer (1:1) with the addition of glu-
cose (1.3 g/l; close to a physiological level), dextran 40
(10 g/l), sodium bicarbonate (2.2 g/l) bovine serum albu-
min (4 per cent), heparin (2500 IU/l) and clamoxyl (250
mg/l). Initial volume used on both sides (maternal and
fetal) was 120–130 ml. The flow rate on the maternal side
and fetal side was 12 and 6 ml/min, respectively. Two oxy-
genators (LSI-OX) are used: 95% N2 plus 5% CO2 for the
fetal circuit and 95% air plus 5% CO2 for the maternal
perfusate respectively. The oxygen level in the perfusion
medium was 130–150 mg Hg (maternal side) and 40–60
mm Hg (fetal side), respectively (Figure 1).
Experiments using a crossover system were performed
according to four different protocols (Table 1) including
always a 20 minute pre-phase of open perfusion of both
compartments to flush the blood out of the intervillous
space and the villous vascular compartment. For each pro-
tocol six experiments, (each on one placenta) were carried
out, so six placentae per group and a total of 24 placentae
for all experiments were used. Each experiment included
two phases (I and II) of 2 hours. The crossover system was
used in relation to the fact that metabolic parameters
measured under control group (protocol A) differ
between phase I (2 hours) and phase II (2 hours) (0.26 vs.
0.18  μmol/g/min glucose consumption; 0.22 vs. 0.18
μmol/g/min lactate production; 60 vs. 37 mU/g/min hCG
accumulation; 82 vs. 66 pg/g/min leptin accumulation).
The same effect was already shown by Miller RK et al.,
1985 [26] and Di Santo et al., [27]. Therefore, in the fol-
lowing experimental groups (protocol B, C, D), eachReproductive Biology and Endocrinology 2009, 7:61 http://www.rbej.com/content/7/1/61
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experiment included a control phase (2 hours), which was
alternately applied either in the phase I or in the phase II,
while the test substances were added in the remaining
other experimental phase. In protocol B methadone
(Sigma Aldrich, Fluka, CH-Buchs) at a concentration of
approximately 500 ng/ml corresponding to plasma levels
following a dose of 120 mg per day was added to the
medium on the maternal side at the beginning of either
phase I or phase II. In protocol C, cocaine (Sigma Aldrich,
Fluka, CH-Buchs) at a concentration of 3 mg/l together
with methadone 500 ng/ml and in protocol D, heroin
[28] 150 ng/ml together with methadone 500 ng/ml
respectively was added. The exact methadone concentra-
tion of used initial maternal medium was verified by ana-
lytical determination simultaneously with the perfusion
samples. The perfusion media were replaced on both
maternal and fetal sides after phase I. In all experiments
45 nCi/ml of 14 [C]antipyrine  (radioactivity: 4.7 mCi/
mmol, Sigma Aldrich, Fluka, CH-Buchs) was added at the
beginning of each phase to the maternal perfusate to
Schematic illustration of the human placenta perfusion model (FA: fetal artery; FV: fetal vein; MA: maternal artery; MV: mater- nal vein) Figure 1
Schematic illustration of the human placenta perfusion model (FA: fetal artery; FV: fetal vein; MA: maternal 
artery; MV: maternal vein).
Table 1: Perfusion of placentae (n = 24) including two phases in a crossover system
Protocol n Phase I (2 hours) Phase II (2 hours)
A3
3
m + antipyrine
m + antipyrine
m + antipyrine
m + antipyrine
B3
3
m + antipyrine
m + antipyrine + methadone
m + antipyrine + methadone
m + antipyrine
C3
3
m + antipyrine
m + antipyrine + methadone + cocaine
m + antipyrine + methadone + cocaine
m + antipyrine
D3
3
m + antipyrine
m + antipyrine + methadone + heroin
m + antipyrine + methadone + heroin
m + antipyrine
Protocol A: control
m: perfusion mediumReproductive Biology and Endocrinology 2009, 7:61 http://www.rbej.com/content/7/1/61
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measure placental permeability from the maternal to the
fetal direction. Antipyrine is a common reference marker
to measure passive diffusion-dependent transfer [29].
Sample collection
Perfusion media aliquots of 5 ml from both sides (fetal
and maternal) were collected at each hour of the per-
fusion and stored at -20°C until analysis of placental
methadone levels, placental metabolism, permeability
and microparticles. Tissue specimens before and after per-
fusion were collected and snap-frozen in liquid nitrogen
and stored at -80°C until analysis of methadone and P-
glycoprotein.
Analytical methods
Concentrations of methadone
Methadone and its primary metabolite (2-ethyliden-1, 5-
dimethyl-3, 3-diphenyl-pyrrolidine = EDDP) were ana-
lyzed using High Pressure Liquid Chromatography
(HPLC) and Mass Spectrometry (MS) [30]. 0.5 ml H2O
and 500 μl 100 mM ammonium carbonate buffer (pH
9.3) were added to 1 ml of the perfusate sample and the
tissue homogenate respectively and then extracted with 5
ml n-hexane/dichlormethane (4:1 ratio v/v). The organic
extract was dried completely with a rotavap (35°C) and
aired additionally under nitrogen (N2). The residue was
dissolved in 100 μl acetonitrile buffer and 300 μl ammo-
nium acetate buffer. Aliquots were analysed by HPLC and
MS. The calibration curve ranged from 0.69 to 828 ng/ml.
Placental metabolism
Glucose and lactate determinations were performed using
an enzymatic assay of hexokinase/glucose-6-phosphate
dehydrogenase and lactate dehydrogenase/glutamate
pyruvate transaminase respectively [31]. Glucose con-
sumption was calculated from the differences between
initial and final levels in the medium on both maternal
and fetal sides and were normalized to wet tissue weight
and length of perfusion period as previously described by
Di Santo et al., 2003 [27]. For the measurement of hCG
and leptin in the medium, standard enzyme-linked-
immunosorbent assays (ELISA) developed earlier by
Malek et al. [21] were used whereas the rate of accumula-
tion was calculated as previously described [32]. Thereby
the respective protein in samples is bounded by-purified
anti-hCG or anti-leptin antibodies (capture antibodies)
and immobilized on plastic plates (NUNC Maxisorpy™
microplates, Nalge Nunc International, Denmark). The
captured protein was detected by a second enzyme-conju-
gated antibody. Following the addition of a chromogenic
substrate, the level of the generated colored product is
measured spectrophotometrically and the protein con-
centration is determined from the respective standard
curve.
Antipyrine transfer
The transfer rate of antipyrine was determined according
to the 14C-labeled antipyrine reference method of Chal-
lier, 1985 [29].
Microparticles
Isolation of microparticles (MPs) was carried out with 10
ml of maternal final perfused medium and centrifugation
at 3'200 × g. The supernatant was centrifuged at 10'000 ×
g and the pellet was re-suspended in 100 μl PBS [33-35].
The protein content was determined using the BCA™ Pro-
tein Assay Kit (Sigma-Aldrich, Buchs, Switzerland) with
bovine serum albumin as a standard. All steps were per-
formed at 4°C [10,16]. Identification of MPs as syncytio-
trophoblastic shedding was performed by flow cytometric
analysis with mouse monoclonal anti-Placental Alkaline
Phosphatase (PLAP) described by Di Santo et al. 2007
[31].
P-glycoprotein
Isolation of brush-border membranes: 3 g tissue (mixed
from three different locations of the placenta collected
before and after perfusion respectively) were dissected
and washed four times with PBS (83 mM NaCl, 22 mM
Na2HPO4, 5.5 mM KH2PO4, pH 7.4). The tissue was
homogenized for 1 minute and the tissue suspension was
centrifuged at 3'200 × g for 10 min and the supernatant
was further centrifuged at 10'000 × g for 30 min. Thereaf-
ter, the supernatant (1.0 ml) was centrifuged again at
100'000 × g (Sorvall Ultraspeed Centrifuge Rotor Log, Thermo
Fisher Scientific) and the pellet was resolved in 100 μl PBS
and used for western blot. Its protein content was deter-
mined using the BCA™ Protein Assay Kit (Sigma-Aldrich,
Buchs, Switzerland) with bovine serum albumin as a stand-
ard. All steps were performed at 4°C [9,20].
Western blot: The identification of P-glycoprotein expres-
sion was achieved using 10.0% SDS/polyacrylamide gel
electrophoresis. The amount of sample protein loaded on
each well was 40 μg. The procedure follows the method of
the trouble shooting protocol of the R&D System [36].
The transfer of the protein on the nitrocellulose mem-
brane (ECL Hybond, nitrocellulose membrane, Amersham
Biosciences, Buckinghamshire) was performed using the
tank blotting system overnight. Non-specific binding
domains were blocked by incubation with 5% non-fat dry
milk in TBS for 1 h. The blots were incubated with the pri-
mary murine monoclonal anti-P-glycoprotein antibody
(diluted 1:200) (Sigma-Aldrich) and the anti-beta-actin
antibody (diluted 1:500) (Sigma-Aldrich) as an internal
standard for one hour. The membrane was washed and
incubated with the goat antimouse horseradish peroxi-
dase-conjugated antibodiy (diluted 1:1000) (Dako) as sec-
ondary antibody for one hour. The detection was carriedReproductive Biology and Endocrinology 2009, 7:61 http://www.rbej.com/content/7/1/61
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out using chemiluminescence and the visualization was
performed at chemiluminescence films (ECC hyper film,
high performance chemiluminescence film, Amersham Bio-
sciences, Buckinghamshire, UK) [9,20]. The density of the
simultaneously obtained bands of P-gp and beta-actin
was measured using a densiometer. Values of P-gp were
normalized to the respective value of the beta-actin in the
same run.
Calculations
The glucose consumption and lactate production were
calculated from the differences between initial and final
levels in the perfusate on both, the maternal and fetal side,
and normalized to tissue weight and length of perfusion
period.
The net production (NP) of hCG and leptin after 4 h was
calculated with the formula NP = Atot + TE - T0, where Atot
means the hormone accumulation in the perfusate, TE the
tissue content determined after perfusion and T0 the tissue
content before initiation of the experiment. Results were
normalized to tissue weight and to T0.
Statistics
Statistical analysis was performed using Prism version 3.0
(GraphPad Software, San Diego California, USA). Mean ±
SD were calculated. The Mann-Whitney U-test was used to
estimate the statistical significance of the differences
between or in experimental groups respectively. Differ-
ences were considered significant if P < 0.05.
Results
Methadone concentration
In the perfusion with methadone alone, a concentration
of 389 ± 79 ng/ml was applied either in the first or in the
second phase (Table 2). After 2 hours the methadone con-
centration in the perfusate from the maternal side as well
as from the fetal side was below the detection limit of <
0.69 ng/ml. In perfusions with methadone plus cocaine 3
mg/l, the methadone uptake was slower, which was indi-
cated by the detection of methadone (1.6 ± 1.1 ng/ml) on
the maternal side, while on the fetal side the level
remained again undetectable. When heroin was added,
the methadone uptake was more reduced than with
cocaine and the concentrations were measurable both, on
the fetal and on the maternal side with a fetal/maternal
ratio of 1:7. In all experiments methadone increased in
the tissue (cotyledon), whereas the highest accumulation
was seen in perfusions with methadone plus heroin
(172% vs. methadone alone, P = 0.008). In cases where
methadone was applied in the first phase of the perfusion,
no methadone could be detected in the perfusates of the
second phase indicating that there was no wash out of
methadone from the tissue. Concentrations of the metab-
olite were under the detection limit in all samples.
Placental metabolism
There was no significant difference in the glucose con-
sumption (μmol/g/min) and lactate production (μmol/g/
min) between phase I (0.16 ± 0.04 glucose; 0.19 ± 0.04
lactate) and phase II (0.14 ± 0.03 glucose; 0.17 ± 0.04 lac-
tate) in any group of perfusion. There was also no signifi-
cant difference between perfusions with and without
drugs (controls).
The tissue content for hCG and leptin was significantly
higher at the end than before the perfusion in all experi-
ments excluding that with methadone/heroin. In case of
methadone/heroin addition the tissue content for hCG
before vs. after perfusion was unchanged whereas the lep-
tin content decreased significantly after perfusion (P  <
0.05). The net production of both hormones when related
to the tissue initial content gave values over 100% in every
group (Table 3).
Transfer of antipyrine
Antipyrine transfer profiles from maternal to fetal side
were similar in phase 1 and phase 2 (control experi-
ments).
Methadone decreased the transfer of antipyrine. The mean
fetal to maternal ratio was 80% (0.50 ± 0.06) of the con-
trol ratio (0.60 ± 0.07, P < 0.01). The perfusion with meth-
adone plus cocaine increased the transfer of antipyrine;
the fetal to maternal ratio was 120% (0.68 ± 0.13) of the
control ratio (0.56 ± 0.08, P = 0.03). A non-significant
Table 2: Methadone concentration measured in the initial maternal medium (M0) and after two hours of perfusion in the maternal 
medium (ME), the fetal medium (FE) and in the perfused tissue (TE)
ME [ng/ml]
(% Recovery)
FE [ng/ml]
(% Recovery)
TE [ng/g]
(% Recovery)
Cotyledon
Weight [g]
Perfusion with methadone (n = 6) <0.69 (0) <0.69 (0) 1987 ± 587 (94) 20.1 ± 3.4
Perfusion with methadone plus cocaine (n = 6) 1.6 ± 1.1 (0.6) <0.69 (0) 2814 ± 352 (96) 19.6 ± 2.3
Perfusion with methadone plus heroin (n = 6) 57 ± 22 (6) 8 ± 10 (1) 3427 ± 374a(92) 20.3 ± 2.7
The detection limit of methadone was 0.69 ng/ml.
Values are mean ± SD
aP < 0.01 vs. perfusion with methadoneReproductive Biology and Endocrinology 2009, 7:61 http://www.rbej.com/content/7/1/61
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increase in the transfer was seen when methadone plus
heroin was perfused indicating a fetal to maternal ratio of
0.71 ± 0.24, which was 127% of the control ratio (0.58 ±
0.21, P = 0.179) (Figure 2).
Microparticles
The concentration of the released microparticles (MPs)
isolated from the maternal side after perfusion without
addition of any drug (control) was 2190 ± 655 ng protein/
g/min. A non-significant reduction in the release of MPs
(96 ± 7% of the the control) was observed when metha-
done was added. The accumulation of MPs increased after
perfusion with methadone/cocaine 128 ± 8% of the con-
trol (P = 0.03). In case of the perfusion with methadone/
heroin the MP's percentage increased to 134 ± 14 of the
control (P = 0.03). No significant difference to the control
was seen after the perfusion of methadone alone (Figure
3). The percentage of trophoblast-derived MPs as indi-
cated by PLAP was unchanged in all experimental groups.
P-glycoprotein
The P-glycoprotein expression (percentage of actin expres-
sion) in the tissue increased significantly during the per-
fusion with methadone alone or methadone in
combination with cocaine or heroin by 49 ± 41% (P =
0.03), 75 ± 63% (P = 0.01) and 59 ± 51% (P = 0.03)
Table 3: Tissue content before perfusion (T0) and after 4 hours of perfusion (TE), accumulation (Atot) and net production (NP) as well 
as percent NP of T0 (% NP) of hCG and leptin
T0 TE Atot NP % NP
Control perfusion
(n = 6)
hCG [mU/g] 6100 ± 4538 9028 ± 7205b 11608 ± 7179 14536 ± 8956 299 ± 80
Leptin [pg/g] 7944 ± 5189 10050 ± 7672c 18122 ± 6824 20228 ± 8752 320 ± 136
Perfusion with methadone
(n = 6)
hCG [mU/g] 3422 ± 2357 3996 ± 1908b 6711 ± 3318 7285 ± 2868 269 ± 59
Leptin [pg/g] 3673 ± 643 5590 ± 3431a 14380 ± 4023 16298 ± 6737 480 ± 257
Perfusion with methadone plus cocaine (n = 6) hCG [mU/g] 4530 ± 2202 5305 ± 4429b 10539 ± 6563 11313 ± 8219 224 ± 116
Leptin [pg/g] 2920 ± 544 4370 ± 2303b 37744 ± 20897 39195 ± 22796 1200 ± 573
Perfusion with methadone plus heroin (n = 6) hCG [mU/g] 3852 ± 1649 4336 ± 2088 5176 ± 2067 5660 ± 2647 169 ± 81
Leptin [pg/g] 9856 ± 6146 5568 ± 2194a 17949 ± 9578 13662 ± 7026 191 ± 573
Values are mean ± SD
a P < 0.05 after vs. before; b P < 0.01 after vs. before; c P < 0.001 after vs. before.
There is no statistical difference in NP of hCG or leptin between control perfusion and each of the other experimental groups.
Effect of methadone (+MTD), methadone plus cocaine  (+MTD+COC) and methadone plus heroin (+MTD+HRO)  on antipyrine transfer Figure 2
Effect of methadone (+MTD), methadone plus 
cocaine (+MTD+COC) and methadone plus heroin 
(+MTD+HRO) on antipyrine transfer. Values are mean 
± SD (n = 6) and expressed as percentage of control (CTR = 
100%). *P < 0.01 vs. CTR, **P = 0.03 vs. CTR.
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Effect of methadone (+MTD), methadone plus cocaine  (+MTD+COC) and methadone plus heroin (+MTD+HRO)  respectively on the release of microparticles into the mater- nal circuit quantified by total protein content Figure 3
Effect of methadone (+MTD), methadone plus 
cocaine (+MTD+COC) and methadone plus heroin 
(+MTD+HRO) respectively on the release of micro-
particles into the maternal circuit quantified by total 
protein content. Values are expressed as mean ± SD (n = 
6) of the percentage of the control (CTR = 100%). *P = 0.03 
vs. CTR
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respectively compared to the tissue before perfusion (con-
trol) (Figure 4A, B).
Discussion
Transplacental transfer of drugs (or other substances) and
the amount that enters the fetal circulation is determined
by at least three processes: simple diffusion, efflux trans-
porters, and biotransformation by metabolic enzymes.
The syncytiotrophoblast layer with the brush border
membrane contains several transporter proteins and is in
direct contact with the maternal blood in the intervillous
space. It's therefore extremely sensitive for changes
induced by maternal uptake. In the present study we
found differing mechanisms of placental function and tis-
sue reaction for methadone perfused in a closed circula-
tion: There was no measurable concentration of
methadone in the fetal circulation when methadone was
perfused alone or with the addition of cocaine or heroin,
respectively. Of course this could be proven in an open
system where the re-uptake of transferred substances
(methadone and heroin) is not possible. However, these
results are in contrast to that of other authors [7,10], who
perfused methadone alone. Nanovskaya et al. demon-
strated a transfer into the fetal circuit of 31% [10] and
Nekhayeva et al. [7] detected methadone in the fetal cir-
cuit already within 5 minutes of its addition to the mater-
nal reservoir even though they used a lower concentration
of methadone than we did (100–400 ng/ml vs. 500 ng/
ml) used. One reason for this difference may be the use of
different methods. While in the study of Nekhayeva IA et
al. [7] the perfusion lasted for 4 hours and methadone was
measured by the radioactivity of the 3H-labelled metha-
done, we perfused methadone only for 2 hours and meas-
ured its concentration by HPLC and MS.
Our control experiments showed similar values for pla-
cental metabolism and function (glucose consumption,
lactate production, production and accumulation of hCG
and leptin) as found in previous studies with the same ex-
vivo placenta perfusion model [21,30-32]. These results
demonstrate that the perfused tissue maintains under in
vitro condition the ability for de-novo synthesis of hCG
and leptin. The addition of cocaine or heroin to metha-
done showed no different results of glucose consumption,
lactate production, hCG accumulation and production.
There was only a nonsignificant difference in the leptin
production in the experiments with heroin. As it was
already observed under in vivo conditions where serum
leptin levels decreased in patients with heroin addiction
[22], the consequences of modified leptin production
during heroin consumption in pregnancy should be veri-
fied in further experiments. Consequently, until now, it
has to be postulated that methadone plus cocaine or
methadone plus heroin do not affect placental viability.
In case of cocaine the present results do not agree with
those reported in a previous study [19,37], where cocaine
(without methadone) led to a significant decrease in the
hCG release to the maternal circuit.
In contrast to Nekhayeva et al., we could show that meth-
adone has a significant influence on placental permeabil-
ity. In the perfusion with methadone alone, the antipyrine
transfer decreased. This fact could lead to a dysfunction in
the supply of the fetus with oxygen and nutrients from the
maternal circulation. Intrauterine growth restriction
observed under in vivo supplementation with methadone
A. Western blot analysis of P-glycoprotein expression in the  isolated brush border membrane before perfusion (T0) and  after perfusion (TE) Figure 4
A. Western blot analysis of P-glycoprotein expres-
sion in the isolated brush border membrane before 
perfusion (T0) and after perfusion (TE). CTR: con-
trol; +MTD: methadone; +MTD+COC: methadone 
plus cocaine; +MTD+HRO: methadone plus heroin. 
B. P-glycoprotein expression (percentage of actin) in 
the isolated brush border membrane after perfusion 
with methadone (TE+MTD), methadone plus 
cocaine (TE+MTD+COC) and methadone plus her-
oin (TE+MTD+HRO). Values are expressed as mean ± SD 
(n = 6) of the percentage of the control (tissue before per-
fusion: T0-CTR = 100%). *P = 0.03 vs. T0-CTR, **P = 0.01 vs. 
T0-CTR, ***P = 0.03 vs. T0-CTR.
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[1] could be based on this mechanism. In contrast to the
experiments with methadone alone antipyrine transfer
increased significantly in the phases where cocaine or her-
oin was added. Even though the supply of the fetus with
oxygen and nutrients may be better, the amelioration of
the placental permeability could affect the barrier func-
tion of the placenta adversely. Consequently, more toxic
substances or bacteria and viruses may cross the placenta
and harm the fetus. Previous studies reported increased
prevalence of infectious diagnoses in cocaine-exposed
infants [38].
Cocaine and heroin increased the MPs production into
the maternal circuit. Previous reports have shown that
under different in vitro conditions the production of MPs
can differ [16,39,40]. Under low oxygen (2%) there was
an increased proliferation of the cytotrophoblast and lack
of the fusion with syncytiotrophoblast, so shedding of
MPs was predominantly the result of necrosis [39]. In this
study we have used the already validated method of the
ex-vivo placenta perfusion using 95% air on the maternal
circuit [33]. It was also shown that, this method is a good
model to investigate the shedding of MPs from synyctio-
trophoblast as a sign for oxidative stress seen in preec-
lampsia [33]. One possibility that we can postulate, is that
methadone alone does not influence the tissue structure
whereas the combination with cocaine and heroin may
induce oxidative stress. Further work is required to con-
firm this and the mechanisms involved.
Methadone is a substrate of the ATP-dependent efflux
transporter P-gp [9-11,41]. Our results showed increasing
expression after perfusion with methadone but no addi-
tional increase if cocaine or heroin were added to metha-
done. As it was shown by other authors P-gp expression is
30% higher in preterm than in term placentas [10].
Increased activity of P-gp may therefore affect the inci-
dence and intensity of NAS in babies of women who were
treated with methadone during pregnancy and who deliv-
ered preterm in most cases.
Conclusion
As the consumption of illegal drugs, especially cocaine is
increasing in many countries as demonstrated by the
World Drug Report 2007 [42], our results concerning
cocaine and heroin causing an increased antipyrine trans-
fer and possibly inducing oxidative stress in placental tis-
sue, although we have not measured it directly, may
improve the practical management in monitoring preg-
nant women. It should clarify the efficiency of a conse-
quent and exclusive maintenance therapy with
methadone during pregnancy.
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